Distress in post-treatment hematological cancer survivors: Prevalence and predictors

J Psychosoc Oncol. 2020 May-Jun;38(3):328-342. doi: 10.1080/07347332.2019.1679320. Epub 2019 Oct 23.

Abstract

Objectives: To calculate the prevalence of psychosocial distress, and identify factors that predict distress, in early post-treatment hematological cancer survivors.Design: Cross-sectional survey containing self-report measures.Sample/Methods: Post-treatment hematological cancer survivors in remission (>18 years) (n = 409) completed questionnaires. Distress was measured with the distress thermometer (DT). Logistic regression was used to identify predictors of distress.Findings: Overall 21.9% (n = 93) of respondents reported significant distress (DT ≥4). Significant distress was twice as high in those born overseas (OR = 2.09, p = .03), 3.5 times higher in those with lower social support (OR = 3.51, p = <.001) and five times higher in those with increased fear of recurrence (OR = 0.17, p = <.001).Implications for Psychosocial Providers: Early identification of distress may decrease psychosocial issues in the post-treatment period, especially as psychosocial services have been shown to improve wellbeing for those who are distressed.

Keywords: hematological cancer; oncology; post-treatment; prevalence; psychosocial distress; survivorship.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cancer Survivors / psychology*
  • Cancer Survivors / statistics & numerical data
  • Cross-Sectional Studies
  • Female
  • Hematologic Neoplasms / psychology
  • Hematologic Neoplasms / therapy*
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Psychological Distress*
  • Risk Factors
  • Surveys and Questionnaires
  • Young Adult